Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

New agent for sudden cardiac death in phase I at Nortran

April 5, 1996

Another antioxidant from Oxis: TX-153

April 5, 1996

BXT-51072 in line for clinical evaluation at Oxis

April 5, 1996

Novel vasoprotectants in AtheroGenics' pipeline

April 5, 1996

PB-005 slated to enter phase II

April 5, 1996

Genentech claims vitronectin antagonists

April 5, 1996

Vitronectin receptor antagonist revealed by SmithKline Beecham

April 5, 1996

New PAF antagonist discovered at Abbott

April 5, 1996

Zeneca selects NMDA antagonist for preclinical study

April 5, 1996

GV-150526A in development for stroke

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 15, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
Biopharma tariffs becoming more than a threat
BioWorld
U.S. tariffs on biopharmaceuticals have advanced beyond administration talking points.As a precursor to tariffs, Commerce Secretary Howard Lutnick initiated an...
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...